Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 129

Similar articles for PubMed (Select 22341232)

1.

High-throughput screening in primary neurons.

Sharma P, Ando DM, Daub A, Kaye JA, Finkbeiner S.

Methods Enzymol. 2012;506:331-60. doi: 10.1016/B978-0-12-391856-7.00041-X.

2.

High-Throughput and High-Content Screening for Huntington’s Disease Therapeutics.

Varma H, Lo DC, Stockwell BR.

In: Lo DC, Hughes RE, editors. Neurobiology of Huntington's Disease: Applications to Drug Discovery. Boca Raton (FL): CRC Press; 2011. Chapter 5.

3.

High content screening in neurodegenerative diseases.

Jain S, van Kesteren RE, Heutink P.

J Vis Exp. 2012 Jan 6;(59):e3452. doi: 10.3791/3452.

4.

High throughput screening technology and the small molecules modulating aging related signals.

Mo C, Zhang W, Liu L, Wang L, Xiao H.

Comb Chem High Throughput Screen. 2012 Mar;15(3):242-52. Review.

PMID:
22221057
5.

High content screening: seeing is believing.

Zanella F, Lorens JB, Link W.

Trends Biotechnol. 2010 May;28(5):237-45. doi: 10.1016/j.tibtech.2010.02.005. Epub 2010 Mar 24. Review.

PMID:
20346526
6.

Live-cell imaging in the study of neurodegeneration.

Bakota L, Brandt R.

Int Rev Cell Mol Biol. 2009;276:49-103. doi: 10.1016/S1937-6448(09)76002-2. Review.

PMID:
19584011
7.

High throughput screening for neurodegeneration and complex disease phenotypes.

Varma H, Lo DC, Stockwell BR.

Comb Chem High Throughput Screen. 2008 Mar;11(3):238-48. Review.

8.

Composite primary neuronal high-content screening assay for Huntington's disease incorporating non-cell-autonomous interactions.

Kaltenbach LS, Bolton MM, Shah B, Kanju PM, Lewis GM, Turmel GJ, Whaley JC, Trask OJ Jr, Lo DC.

J Biomol Screen. 2010 Aug;15(7):806-19. doi: 10.1177/1087057110373392. Epub 2010 Jun 25.

PMID:
20581077
9.

A dual-readout F2 assay that combines fluorescence resonance energy transfer and fluorescence polarization for monitoring bimolecular interactions.

Du Y, Nikolovska-Coleska Z, Qui M, Li L, Lewis I, Dingledine R, Stuckey JA, Krajewski K, Roller PP, Wang S, Fu H.

Assay Drug Dev Technol. 2011 Aug;9(4):382-93. doi: 10.1089/adt.2010.0292. Epub 2011 Mar 11.

10.

Technological advances in high-throughput screening.

Liu B, Li S, Hu J.

Am J Pharmacogenomics. 2004;4(4):263-76. Review.

PMID:
15287820
11.

An image analysis toolbox for high-throughput C. elegans assays.

Wählby C, Kamentsky L, Liu ZH, Riklin-Raviv T, Conery AL, O'Rourke EJ, Sokolnicki KL, Visvikis O, Ljosa V, Irazoqui JE, Golland P, Ruvkun G, Ausubel FM, Carpenter AE.

Nat Methods. 2012 Apr 22;9(7):714-6. doi: 10.1038/nmeth.1984.

12.

Primary cells and stem cells in drug discovery: emerging tools for high-throughput screening.

Eglen R, Reisine T.

Assay Drug Dev Technol. 2011 Apr;9(2):108-24. doi: 10.1089/adt.2010.0305. Epub 2010 Dec 27. Review.

PMID:
21186936
13.

HCS-Neurons: identifying phenotypic changes in multi-neuron images upon drug treatments of high-content screening.

Charoenkwan P, Hwang E, Cutler RW, Lee HC, Ko LW, Huang HL, Ho SY.

BMC Bioinformatics. 2013;14 Suppl 16:S12. doi: 10.1186/1471-2105-14-S16-S12. Epub 2013 Oct 22.

14.

Rethinking molecular similarity: comparing compounds on the basis of biological activity.

Petrone PM, Simms B, Nigsch F, Lounkine E, Kutchukian P, Cornett A, Deng Z, Davies JW, Jenkins JL, Glick M.

ACS Chem Biol. 2012 Aug 17;7(8):1399-409. doi: 10.1021/cb3001028. Epub 2012 May 31.

PMID:
22594495
15.

Modeling neurodegenerative diseases in Caenorhabditis elegans.

Li J, Le W.

Exp Neurol. 2013 Dec;250:94-103. doi: 10.1016/j.expneurol.2013.09.024. Epub 2013 Oct 2. Review.

PMID:
24095843
16.

High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array.

Tung YC, Hsiao AY, Allen SG, Torisawa YS, Ho M, Takayama S.

Analyst. 2011 Feb 7;136(3):473-8. doi: 10.1039/c0an00609b. Epub 2010 Oct 21.

PMID:
20967331
17.

From c-Photina mouse embryonic stem cells to high-throughput screening of differentiated neural cells via an intermediate step enriched in neural precursor cells.

Cainarca S, Fenu S, Bovolenta S, Arioli P, Menegon A, Lohmer S, Corazza S.

J Biomol Screen. 2010 Oct;15(9):1132-43. doi: 10.1177/1087057110379267. Epub 2010 Sep 10.

PMID:
20834010
18.

A quantitative analytic pipeline for evaluating neuronal activities by high-throughput synaptic vesicle imaging.

Fan J, Xia X, Li Y, Dy JG, Wong ST.

Neuroimage. 2012 Sep;62(3):2040-54. doi: 10.1016/j.neuroimage.2012.06.020. Epub 2012 Jun 23.

19.

Monitoring of HTS compound library quality via a high-resolution image acquisition and processing instrument.

Baillargeon P, Scampavia L, Einsteder R, Hodder P.

J Lab Autom. 2011 Jun;16(3):197-203. doi: 10.1016/j.jala.2011.02.004. Epub 2011 May 16.

20.

A 1536-well quantitative high-throughput screen to identify compounds targeting cancer stem cells.

Mathews LA, Keller JM, Goodwin BL, Guha R, Shinn P, Mull R, Thomas CJ, de Kluyver RL, Sayers TJ, Ferrer M.

J Biomol Screen. 2012 Oct;17(9):1231-42. Epub 2012 Aug 27.

PMID:
22927676
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk